Delivery Order SPE2DB20D3103-SPE2DB24FQ1U0

Award Date 9/5/24
Potential Completion Date 9/6/24
Potential Value $11K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded to Amerisourcebergen Drug Corporation, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The $1,000.60 firm fixed-price contract is for the supply of 4,565,670,077 units of Atomoxetine HCL 40 mg capsules, a medication used to treat attention-deficit/hyperactivity disorder (ADHD). The contract has a completion date of September 5, 2024 and is not designated as a set-aside. Amerisourcebergen holds a larger...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Atomoxetine HCL 40 mg capsules. The firm-fixed-price contract, which does not have a set-aside designation, has a ceiling value of $1,891.58 and an ultimate completion date of September 30, 2024. AmerisourceBergen, through its Corporate Office Division, is a key contractor for providing a wide range of prescription medications,...
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,565,255 units of Atomoxetine HCL 40 mg capsules. The contract has a Firm Fixed Price (FFP) pricing structure and a total ceiling value of $1,307.21. It was awarded on July 25, 2024 with a period of performance through July 26, 2024. This contract represents a delivery order under AmerisourceBergen's $999,999,999 Indefinite...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,566,281,057 units of Atomoxetine HCl 60 mg capsules. The delivery order is a firm-fixed price contract with a ceiling value of $1,022.40 and a period of performance through October 31, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, was issued by the Defense Logistics Agency (DLA). The $1,134.63 firm fixed-price delivery order is for the supply of 4,566,817,731 units of the drug Atomoxetine HCL 25 mg capsules. The contract has an ultimate completion date of January 2, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of Atomoxetine HCL 18 mg capsules, with a ceiling value of $2,205.42 and a performance period extending to May 27, 2025. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite...
This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a for-profit subsidiary of Amerisourcebergen Corporation. The contract is for the delivery of 4,563,714,904 capsules of the pharmaceutical Atomoxetine HCl 40 mg, with a completion date of February 21, 2024 and an award date of February 20, 2024. The potential value of this single award is $1,190.07. Amerisourcebergen Drug Corp is the prime...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is for the delivery of 18 mg capsules of the drug Atomoxetine HCL, with a ceiling value of $1,180.72 and a completion date of April 9, 2025. The contract is a Delivery Order, with a Firm Fixed Price pricing type. It is not designated as a set-aside contract. Amerisourcebergen Drug Corp is the prime contractor, and there are no major...
This is a delivery order award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, under the Defense Logistics Agency (DLA) Troop Support Medical Indefinite Delivery Contract valued at up to $999,999,999. The award is for $1,871.99 to supply 4,565,536,224 units of the prescription medication Atomoxetine Hydrochloride 40mg capsules. This order is not set aside for any small business or other socioeconomic program. The award has a firm fixed-price pricing type and an ultimate...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a global pharmaceutical distribution company. The order is for the supply of Atomoxetine HCL 10 mg capsules. The contract is a firm fixed price delivery order with a potential value of $1,598.88 and a completion date of February 20, 2024. There is no set-aside designation for this order. Amerisourcebergen Drug Corp is the...
  • SPE2DB20D3103
    Indefinite Delivery Contract
  • SPE2DB20D3103-SPE2DB24FQ1U0
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $11,400.42 firm fixed-price contract is for the supply of 4,565,699 units of Atomoxetine HCL 80 mg capsules to support federal healthcare programs. This order is a part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 that Amerisourcebergen holds with DLA Troop Support Medical for delivering a wide range of medical commodities to military treatment facilities and other government healthcare providers. The contract has a completion date of September 6, 2024 and does not utilize any set-aside designations.

Generated 12/5/24, 9:03 AM